» Articles » PMID: 28672952

Emodin Protects Against Oxidative Stress and Apoptosis in HK-2 Renal Tubular Epithelial Cells After Hypoxia/reoxygenation

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2017 Jul 5
PMID 28672952
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to determine the effects of emodin, a natural compound with antioxidant properties, on oxidative stress and apoptosis induced by hypoxia/reoxygenation (H/R) in HK-2 human renal tubular cells. In HK-2 cells subjected to H/R, it was observed that pre-treatment with emodin lead to an increase in cellular viability and a reduction in the rate of apoptosis and the B-cell lymphoma 2 (Bcl-2)-associated X protein/Bcl-2 ratio. H/R alone caused a significant increase in the levels of reactive oxygen species and malondialdehyde (P<0.05) and a significant decrease in the activities of superoxide dismutase, catalase and glutathione peroxidase (P<0.05), relative to normoxic cells. In turn, parameters of oxidative stress were improved by emodin pre-treatment. In addition, emodin pre-treatment significantly inhibited the phosphorylation of extracellular signal-regulated protein kinase and c-Jun N-terminal kinase mitogen-activated protein kinases (MAPKs) induced by H/R (P<0.05). These data suggest that emodin may prevent H/R-induced apoptosis in human renal tubular cells through the regulation of cellular oxidative stress, MAPK activation and restoration of the Bax/Bcl-2 ratio.

Citing Articles

Emodin improves the cardiac function in the rats with chronic heart failure through regulation of the miR-26b-5p/PTEN pathway.

Gu Z, Zhang S, Zhao S, Cui Y, Sun L Arch Med Sci. 2024; 20(2):655-663.

PMID: 38757011 PMC: 11094829. DOI: 10.5114/aoms.2020.96345.


Emodin prevents renal ischemia-reperfusion injury via suppression of p53-mediated cell apoptosis based on network pharmacology.

Lu H, Xie D, Qu B, Li M, He Y, Liu W Heliyon. 2023; 9(5):e15682.

PMID: 37215853 PMC: 10195913. DOI: 10.1016/j.heliyon.2023.e15682.


The In Vitro Anti-Parasitic Activities of Emodin toward .

Adeyemi O, Ishii K, Kato K Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986545 PMC: 10053859. DOI: 10.3390/ph16030447.


Cerium oxide-based nanozyme suppresses kidney calcium oxalate crystal depositions via reversing hyperoxaluria-induced oxidative stress damage.

Deng J, Yu B, Chang Z, Wu S, Li G, Chen W J Nanobiotechnology. 2022; 20(1):516.

PMID: 36482378 PMC: 9733203. DOI: 10.1186/s12951-022-01726-w.


The progress and prospect of natural components in rhubarb () in the treatment of renal fibrosis.

Wang Y, Yu F, Li A, He Z, Qu C, He C Front Pharmacol. 2022; 13:919967.

PMID: 36105187 PMC: 9465315. DOI: 10.3389/fphar.2022.919967.


References
1.
Bae E, Cho S, Joo S, Ma S, Kim S, Lee J . 4-Hydroxy-2-hexenal-induced apoptosis in human renal proximal tubular epithelial cells. Nephrol Dial Transplant. 2011; 26(12):3866-73. DOI: 10.1093/ndt/gfr386. View

2.
Lee D, Park S, Bae S, Jeong D, Park M, Kang C . Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury. Sci Rep. 2015; 5:16592. PMC: 4643254. DOI: 10.1038/srep16592. View

3.
Cai Q, Ma T, Li C, Tian Y, Li H . Catalpol Protects Pre-Myelinating Oligodendrocytes against Ischemia-induced Oxidative Injury through ERK1/2 Signaling Pathway. Int J Biol Sci. 2016; 12(12):1415-1426. PMC: 5166484. DOI: 10.7150/ijbs.16823. View

4.
Du Y, Ko K . Effects of emodin treatment on mitochondrial ATP generation capacity and antioxidant components as well as susceptibility to ischemia-reperfusion injury in rat hearts: single versus multiple doses and gender difference. Life Sci. 2005; 77(22):2770-82. DOI: 10.1016/j.lfs.2005.03.027. View

5.
Guan X, Qian Y, Shen Y, Zhang L, Du Y, Dai H . Autophagy protects renal tubular cells against ischemia / reperfusion injury in a time-dependent manner. Cell Physiol Biochem. 2015; 36(1):285-98. DOI: 10.1159/000374071. View